7
Participants
Start Date
July 31, 2009
Primary Completion Date
August 31, 2009
Study Completion Date
August 31, 2009
Dapagliflozin
Tablet and IV solution, Oral and IV, 10 mg po and 100 µg IV, Single oral dose followed by a single IV dose (IV dose administered at 1h after oral dose), 1 day
Covance Clinical Research Unit, Inc., Madison
Lead Sponsor
Collaborators (1)
Bristol-Myers Squibb
INDUSTRY
AstraZeneca
INDUSTRY